PFS as a surrogate end point for OS in advanced colorectal cancer trials

Studies examining the prognostic significance of melanoma of unknown primary (MUP) have produced inconsistent results and it is unclear whether patients with MUP require moreaggressive management than patients with known primary melanoma (MKP). Now, Lee et al. have commented that they have conducted the largest ever review of the outcomes of patients with… CONTINUE READING